As pharmaceutical industry retreats, research and development for tuberculosis treatments, diagnostics and prevention relies more than ever on government support, and it’s dropping, Treatment Action Group report shows . . . LIVERPOOL, England – The chance to have the right people and the right information in the right place at the same time comes all too rarely […]
LIVERPOOL, England – While much of the focus at this conference focuses on the pursuit of new knowledge, to better treat, diagnose and prevent tuberculosis, a group of experts from leading institutions worldwide have put together everything they currently know about the disease in 23 pages. Among the points, lead author Madhukar Pai said today, as […]
HIV
Leader Needed to Fight Another Pandemic: HIV – While the COVID-19 pandemic has disrupted HIV services worldwide, the office of U.S. Global AIDS Coordinator has remained […]
Tuberculosis
In the six weeks before South Africa responded its first diagnoses of COVID-19 with the start of physical distancing measures, more than 47,000 people on average […]
Research & Development
By Mitchell Warren, executive director, AVAC In February 2020, just as the COVID pandemic began its rapid global spread, a major HIV vaccine trial called HVTN […]
Policy
By Karen Carvajal, M.D. Over the course of human history we have come a long way in our fight against the threat of infectious diseases and, […]